메뉴 건너뛰기




Volumn 9, Issue 12, 2016, Pages 1246-1255

Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial

(18)  Alfonso, Fernando a   Pérez Vizcayno, María José b,c   García del Blanco, Bruno d   Otaegui, Imanol d   Masotti, Mónica e   Zueco, Javier f   Veláquez, Maite g   Sanchís, Juan h   García Touchard, Arturo i   Lázaro García, Rosa j   Moreu, José k   Bethencourt, Armando l   Cuesta, Javier a   Rivero, Fernando a   Cárdenas, Alberto c   Gonzalo, Nieves c   Jiménez Quevedo, Pilar c   Fernández, Cristina c  


Author keywords

drug eluting balloon(s); drug eluting stent(s); everolimus eluting stent(s); in stent restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; EVEROLIMUS; METAL; PACLITAXEL;

EID: 84994018418     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.03.037     Document Type: Article
Times cited : (54)

References (31)
  • 1
    • 84872447171 scopus 로고    scopus 로고
    • Drug-eluting coronary-artery stents
    • 1 Stefanini, G.G., Holmes, D.R. Jr., Drug-eluting coronary-artery stents. N Engl J Med 368 (2013), 254–265.
    • (2013) N Engl J Med , vol.368 , pp. 254-265
    • Stefanini, G.G.1    Holmes, D.R.2
  • 2
    • 84951574095 scopus 로고    scopus 로고
    • Spanish Cardiac Catheterization and Coronary Intervention Registry. 24th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990–2014)
    • 2 García del Blanco, B., Hernández Hernández, F., Rumoroso Cuevas, J.R., Trillo Nouche, R., Spanish Cardiac Catheterization and Coronary Intervention Registry. 24th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990–2014). Rev Esp Cardiol 68 (2015), 1154–1164.
    • (2015) Rev Esp Cardiol , vol.68 , pp. 1154-1164
    • García del Blanco, B.1    Hernández Hernández, F.2    Rumoroso Cuevas, J.R.3    Trillo Nouche, R.4
  • 5
    • 0041363363 scopus 로고    scopus 로고
    • A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis
    • 5 Alfonso, F., Zueco, J., Cequier, A., et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 42 (2003), 796–805.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 796-805
    • Alfonso, F.1    Zueco, J.2    Cequier, A.3
  • 6
    • 19944425945 scopus 로고    scopus 로고
    • Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial
    • 6 Kastrati, A., Mehilli, J., von Beckerath, N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005), 165–171.
    • (2005) JAMA , vol.293 , pp. 165-171
    • Kastrati, A.1    Mehilli, J.2    von Beckerath, N.3
  • 7
    • 33645533352 scopus 로고    scopus 로고
    • A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial
    • 7 Alfonso, F., Pérez-Vizcayno, M.J., Hernandez, R., et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 47 (2006), 2152–2160.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2152-2160
    • Alfonso, F.1    Pérez-Vizcayno, M.J.2    Hernandez, R.3
  • 8
    • 77953098629 scopus 로고    scopus 로고
    • Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study
    • for the ISAR-DESIRE 2 Investigators
    • 8 Mehilli, J., Byrne, R.A., Tiroch, K., et al., for the ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 55 (2010), 2710–2716.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2710-2716
    • Mehilli, J.1    Byrne, R.A.2    Tiroch, K.3
  • 9
    • 84864029854 scopus 로고    scopus 로고
    • Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent])
    • 9 Alfonso, F., Pérez-Vizcayno, M.J., Dutary, J., et al. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). J Am Coll Cardiol Intv 5 (2012), 728–737.
    • (2012) J Am Coll Cardiol Intv , vol.5 , pp. 728-737
    • Alfonso, F.1    Pérez-Vizcayno, M.J.2    Dutary, J.3
  • 10
    • 33751009078 scopus 로고    scopus 로고
    • Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    • 10 Scheller, B., Hehrlein, C., Bocksch, W., et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355 (2006), 2113–2124.
    • (2006) N Engl J Med , vol.355 , pp. 2113-2124
    • Scheller, B.1    Hehrlein, C.2    Bocksch, W.3
  • 11
    • 67649516634 scopus 로고    scopus 로고
    • Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis
    • 11 Unverdorben, M., Vallbracht, C., Cremers, B., et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119 (2009), 2986–2994.
    • (2009) Circulation , vol.119 , pp. 2986-2994
    • Unverdorben, M.1    Vallbracht, C.2    Cremers, B.3
  • 12
    • 79951990739 scopus 로고    scopus 로고
    • Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis
    • 12 Habara, S., Mitsudo, K., Kadota, K., et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. J Am Coll Cardiol Intv 4 (2011), 149–154.
    • (2011) J Am Coll Cardiol Intv , vol.4 , pp. 149-154
    • Habara, S.1    Mitsudo, K.2    Kadota, K.3
  • 13
    • 84859426601 scopus 로고    scopus 로고
    • A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study
    • 13 Rittger, H., Brachmann, J., Sinha, A.M., et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59 (2012), 1377–1382.
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1377-1382
    • Rittger, H.1    Brachmann, J.2    Sinha, A.M.3
  • 14
    • 84883781403 scopus 로고    scopus 로고
    • A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis
    • 14 Habara, S., Iwabuchi, M., Inoue, N., et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 166 (2013), 527–533.
    • (2013) Am Heart J , vol.166 , pp. 527-533
    • Habara, S.1    Iwabuchi, M.2    Inoue, N.3
  • 15
    • 84873706439 scopus 로고    scopus 로고
    • Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial
    • 15 Byrne, R.A., Neumann, F.J., Mehilli, J., et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381 (2013), 461–467.
    • (2013) Lancet , vol.381 , pp. 461-467
    • Byrne, R.A.1    Neumann, F.J.2    Mehilli, J.3
  • 16
    • 84894347633 scopus 로고    scopus 로고
    • PEPCAD China ISR. A prospective, multicentre, randomized trial, of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of in-stent restenosis
    • 16 Xu, B., Gao, R., Wang, J., et al. PEPCAD China ISR. A prospective, multicentre, randomized trial, of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of in-stent restenosis. J Am Coll Cardiol Intv 7 (2014), 204–211.
    • (2014) J Am Coll Cardiol Intv , vol.7 , pp. 204-211
    • Xu, B.1    Gao, R.2    Wang, J.3
  • 17
    • 84913619061 scopus 로고    scopus 로고
    • 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    • 17 Windecker, S., Kolh, P., Alfonso, F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35 (2014), 2541–2619.
    • (2014) Eur Heart J , vol.35 , pp. 2541-2619
    • Windecker, S.1    Kolh, P.2    Alfonso, F.3
  • 18
    • 79959496041 scopus 로고    scopus 로고
    • Second-generation drug-eluting stents. Moving the field forward
    • 18 Alfonso, F., Fernandez, C., Second-generation drug-eluting stents. Moving the field forward. J Am Coll Cardiol 58 (2011), 26–29.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 26-29
    • Alfonso, F.1    Fernandez, C.2
  • 19
    • 84859586982 scopus 로고    scopus 로고
    • Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
    • 19 Palmerini, T., Biondi-Zoccai, G., Della Riva, D., et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379 (2012), 1393–1402.
    • (2012) Lancet , vol.379 , pp. 1393-1402
    • Palmerini, T.1    Biondi-Zoccai, G.2    Della Riva, D.3
  • 20
    • 84897982628 scopus 로고    scopus 로고
    • A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V clinical trial
    • 20 Alfonso, F., Pérez-Vizcayno, M.J., Cárdenas, A., et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V clinical trial. J Am Coll Cardiol 63 (2014), 1378–1386.
    • (2014) J Am Coll Cardiol , vol.63 , pp. 1378-1386
    • Alfonso, F.1    Pérez-Vizcayno, M.J.2    Cárdenas, A.3
  • 21
    • 84937399147 scopus 로고    scopus 로고
    • A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents. The RIBS IV clinical trial
    • 21 Alfonso, F., Pérez-Vizcayno, M.J., Cárdenas, A., et al. A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents. The RIBS IV clinical trial. J Am Coll Cardiol 66 (2015), 23–33.
    • (2015) J Am Coll Cardiol , vol.66 , pp. 23-33
    • Alfonso, F.1    Pérez-Vizcayno, M.J.2    Cárdenas, A.3
  • 22
    • 34247558672 scopus 로고    scopus 로고
    • Clinical end-points in coronary stent trials. A case for standardized definitions
    • 22 Cutlip, D.E., Windecker, S., Mehran, R., et al. Clinical end-points in coronary stent trials. A case for standardized definitions. Circulation 115 (2007), 2344–2351.
    • (2007) Circulation , vol.115 , pp. 2344-2351
    • Cutlip, D.E.1    Windecker, S.2    Mehran, R.3
  • 23
    • 0033517846 scopus 로고    scopus 로고
    • Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome
    • 23 Mehran, R., Dangas, G., Abizaid, A.S., et al. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 100 (1999), 1872–1878.
    • (1999) Circulation , vol.100 , pp. 1872-1878
    • Mehran, R.1    Dangas, G.2    Abizaid, A.S.3
  • 24
    • 33344460143 scopus 로고    scopus 로고
    • Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis
    • 24 Alfonso, F., Cequier, A., Angel, J., et al. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Am Heart J 151 (2006), 681.e1–681.e9.
    • (2006) Am Heart J , vol.151 , pp. 681.e1-681.e9
    • Alfonso, F.1    Cequier, A.2    Angel, J.3
  • 25
    • 84858770246 scopus 로고    scopus 로고
    • Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    • 25 Scheller, B., Clever, Y.P., Kelsch, B., Hehrlein, C., et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. J Am Coll Cardiol Intv 5 (2012), 323–330.
    • (2012) J Am Coll Cardiol Intv , vol.5 , pp. 323-330
    • Scheller, B.1    Clever, Y.P.2    Kelsch, B.3    Hehrlein, C.4
  • 26
    • 84931561956 scopus 로고    scopus 로고
    • Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of a randomized controlled trial
    • 26 Kufner, S., Cassese, S., Valeskini, M., et al. Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of a randomized controlled trial. J Am Coll Cardiol Intv 8 (2015), 877–884.
    • (2015) J Am Coll Cardiol Intv , vol.8 , pp. 877-884
    • Kufner, S.1    Cassese, S.2    Valeskini, M.3
  • 27
    • 84931560159 scopus 로고    scopus 로고
    • Lower mortality of paclitaxel-coated balloon compared with paclitaxel-eluting stent for the treatment of DES in-stent restenosis: two-year follow-up of the PEPCAD China ISR trial
    • 27 Zhao, Y., Xu, B., Ge, J., et al. Lower mortality of paclitaxel-coated balloon compared with paclitaxel-eluting stent for the treatment of DES in-stent restenosis: two-year follow-up of the PEPCAD China ISR trial. J Am Coll Cardiol, 64(11 Suppl B), 2014, B78.
    • (2014) J Am Coll Cardiol , vol.64 , Issue.11 Suppl B , pp. B78
    • Zhao, Y.1    Xu, B.2    Ge, J.3
  • 28
    • 84952043600 scopus 로고    scopus 로고
    • Long-term outcomes after treatment with a paclitaxel-coated balloon versus balloon angioplasty: insights from the PEPCAD-DES study (Treatment of Drug-Eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter)
    • 28 Rittger, H., Waliszewski, M., Brachmann, J., et al. Long-term outcomes after treatment with a paclitaxel-coated balloon versus balloon angioplasty: insights from the PEPCAD-DES study (Treatment of Drug-Eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). J Am Coll Cardiol Intv 8 (2015), 1695–1700.
    • (2015) J Am Coll Cardiol Intv , vol.8 , pp. 1695-1700
    • Rittger, H.1    Waliszewski, M.2    Brachmann, J.3
  • 29
    • 84954203135 scopus 로고    scopus 로고
    • Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study
    • 29 Unverdorben, M., Vallbracht, C., Cremers, B., et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention 11 (2015), 926–934.
    • (2015) EuroIntervention , vol.11 , pp. 926-934
    • Unverdorben, M.1    Vallbracht, C.2    Cremers, B.3
  • 30
    • 84937389304 scopus 로고    scopus 로고
    • Late restenosis after paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis
    • 30 Habara, S., Kadota, K., Shimada, T., et al. Late restenosis after paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis. J Am Coll Cardiol 66 (2015), 14–22.
    • (2015) J Am Coll Cardiol , vol.66 , pp. 14-22
    • Habara, S.1    Kadota, K.2    Shimada, T.3
  • 31
    • 84946422804 scopus 로고    scopus 로고
    • Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
    • 31 Nijhoff, F., Stella, P.R., Troost, M.S., et al. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis. Clin Res Cardiol 105 (2016), 401–411.
    • (2016) Clin Res Cardiol , vol.105 , pp. 401-411
    • Nijhoff, F.1    Stella, P.R.2    Troost, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.